{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:16:09Z","timestamp":1787681769822,"version":"build-2784847793"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"am","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010793","name":"Pfizer Japan Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007132","name":"Otsuka Pharmaceutical Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006453","name":"Taisho Pharma Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015731","name":"Bayer Yakuhin Kabushiki Kaisha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002975","name":"Sumitomo Pharma Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jiac.2025.102789","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T15:50:59Z","timestamp":1754668259000},"page":"102789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incidence of and risk factors for side effects associated with antibiotic treatment for pneumonia"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0912-1963","authenticated-orcid":false,"given":"Nobuyoshi","family":"Hamao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3109-898X","authenticated-orcid":false,"given":"Isao","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9624-7678","authenticated-orcid":false,"given":"Issei","family":"Oi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0363-5402","authenticated-orcid":false,"given":"Yoshiro","family":"Yasutomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seizo","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7431-9044","authenticated-orcid":false,"given":"Toyohiro","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jiac.2025.102789_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10096-005-1287-9","article-title":"Role of beta-lactam agents in the treatment of community-acquired pneumonia","volume":"24","author":"Garau","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2025.102789_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2169\/internalmedicine.48.1614","article-title":"A clinical comparative study of piperacillin and sulbactam\/ampicillin in patients with community-acquired bacterial pneumonia","volume":"48","author":"Seki","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2025.102789_bib3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/AAC.42.4.729","article-title":"Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia","volume":"42","author":"Zervos","year":"1998","journal-title":"Cefepime Study Group Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102789_bib4","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/00042737-200512000-00015","article-title":"Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication","volume":"17","author":"Duman","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"42","key":"10.1016\/j.jiac.2025.102789_bib5","doi-asserted-by":"crossref","first-page":"15837","DOI":"10.3748\/wjg.v20.i42.15837","article-title":"Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea","volume":"20","author":"Dietrich","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"57","key":"10.1016\/j.jiac.2025.102789_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17570","volume":"17","author":"Allen","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jiac.2025.102789_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12879-015-0869-0","article-title":"Prevalence and management of antibiotic associated diarrhea in general hospitals","volume":"15","author":"Elseviers","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.jiac.2025.102789_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1086\/522187","article-title":"Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system","volume":"45","author":"McFarland","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jiac.2025.102789_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/526530","article-title":"Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients","volume":"46","author":"Dubberke","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jiac.2025.102789_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40360-023-00710-w","article-title":"Antibiotics and antibiotic-associated diarrhea: a real-world disproportionality study of the FDA adverse event reporting system from 2004 to 2022","volume":"24","author":"Huang","year":"2023","journal-title":"BMC Pharmacol Toxicol"},{"issue":"2","key":"10.1016\/j.jiac.2025.102789_bib11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: a French population-based study","volume":"36","author":"Sgro","year":"2002","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jiac.2025.102789_bib12","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bj\u00f6rnsson","year":"2013","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jiac.2025.102789_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2796.1992.tb00562.x","article-title":"Drug-induced hepatic injury: an analysis of 1100 cases reported to the Danish Committee on Adverse Drug Reactions between 1978 and 1987","volume":"232","author":"Friis","year":"1992","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.jiac.2025.102789_bib14","first-page":"765","article-title":"Rates of cutaneous reactions to drugs","volume":"137","author":"Bigby","year":"2001","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jiac.2025.102789_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00228-020-03005-9","article-title":"Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review","volume":"77","author":"Sharifzadeh","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.jiac.2025.102789_bib16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pupt.2010.05.007","article-title":"Tazobactam\/piperacillin for moderate-to-severe pneumonia in patients with risk for aspiration: comparison with imipenem\/cilastatin","volume":"23","author":"Ito","year":"2010","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.jiac.2025.102789_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2025.102789_bib18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jiac.2025.102789_bib19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102789_bib20","first-page":"986","article-title":"Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society","volume":"11","year":"1998","journal-title":"Eur Respir J, Euro Respiratory Soc Euro Respiratory Soc,\" (In Eng)"},{"issue":"7","key":"10.1016\/j.jiac.2025.102789_bib21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2169\/internalmedicine.45.1691","article-title":"The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations","volume":"45","author":"Miyashita","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2025.102789_bib22","series-title":"Drug prescribing in renal failure","year":"1999"},{"key":"10.1016\/j.jiac.2025.102789_bib23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","volume":"11","author":"B\u00e9nichou","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.jiac.2025.102789_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1592\/phco.30.1.57","article-title":"Drug fever","volume":"30","author":"Patel","year":"2010","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.jiac.2025.102789_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/14740338.2018.1462334","article-title":"An update on adverse drug reactions related to \u03b2-lactam antibiotics","volume":"17","author":"Vardakas","year":"2018","journal-title":"Expet Opin Drug Saf"},{"issue":"3","key":"10.1016\/j.jiac.2025.102789_bib26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/CCM.0b013e318236f473","article-title":"Analysis of risk factors for adverse drug events in critically ill patients","volume":"40","author":"Kane-Gill","year":"2012","journal-title":"Crit Care Med"},{"issue":"12 Pt 1","key":"10.1016\/j.jiac.2025.102789_bib27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00005","article-title":"Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost","volume":"128","author":"Climo","year":"1998","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jiac.2025.102789_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/47.1.43","article-title":"Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study","volume":"47","author":"Wistr\u00f6m","year":"2001","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.jiac.2025.102789_bib29","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s10096-012-1603-0","article-title":"Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study","volume":"31","author":"Vesteinsdottir","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2025.102789_bib30","first-page":"175","article-title":"Risk factors for the induction of antibiotic-associated diarrhea","volume":"23","author":"Koizumi","year":"2008","journal-title":"Jpn, J Infect Prev Control"},{"key":"10.1016\/j.jiac.2025.102789_bib31","first-page":"28","article-title":"Analysis of Clostridium difficile-associated diarrhea in Kumiai hospital","volume":"54","author":"Yokoyama","year":"2005","journal-title":"J Jpn Assoc Rural Med"},{"issue":"11","key":"10.1016\/j.jiac.2025.102789_bib32","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jiph.2021.09.016","article-title":"Risk factors for recurrence of clostridioides difficile in hospitalized patients","volume":"14","author":"Alrahmany","year":"2021","journal-title":"J Infect Public Health"},{"issue":"5","key":"10.1016\/j.jiac.2025.102789_bib33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2217\/17460913.3.5.563","article-title":"Antibiotic-associated diarrhea: epidemiology, trends and treatment","volume":"3","author":"McFarland","year":"2008","journal-title":"Future Microbiol"},{"issue":"9","key":"10.1016\/j.jiac.2025.102789_bib34","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1473-3099(15)00151-6","article-title":"Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort study","volume":"15","author":"Shindo","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2025.102789_bib35","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2147\/CIA.S150499","article-title":"Impact of the number of aspiration risk factors on mortality and recurrence in community-onset pneumonia","volume":"12","author":"Noguchi","year":"2017","journal-title":"Clin Interv Aging"},{"issue":"3","key":"10.1016\/j.jiac.2025.102789_bib36","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3143\/geriatrics.52.260","article-title":"Long-term care level as a predictor of a poor outcome in elderly patients with pneumonia","volume":"52","author":"Miyagishima","year":"2015","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"10.1016\/j.jiac.2025.102789_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ph14050441","article-title":"Second-generation cephalosporins-associated drug-induced liver disease: a study in VigiBase with a focus on the elderly","volume":"14","author":"Sipos","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"11","key":"10.1016\/j.jiac.2025.102789_bib38","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1111\/bcp.14847","article-title":"Incidence, characteristics and risk factors for drug-induced liver injury in hospitalized patients: a matched case-control study","volume":"87","author":"Kong","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.jiac.2025.102789_bib39","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Spanish Group for the Study of Drug-Induced Liver Disease. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jiac.2025.102789_bib40","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jiac.2025.102789_bib41","doi-asserted-by":"crossref","first-page":"642","DOI":"10.21037\/atm-20-5144","article-title":"Prevalence and clinical characteristics of antibiotics associated drug induced liver injury","volume":"9","author":"Park","year":"2021","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/j.jiac.2025.102789_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1872-034X.2008.00400.x","article-title":"Recent status of drug-induced liver injury","volume":"39","author":"Takikawa","year":"2009","journal-title":"Hepatol Res"},{"issue":"7","key":"10.1016\/j.jiac.2025.102789_bib43","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ajg.2014.131","article-title":"Practice parameters committee of the American college of gastroenterology. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury","volume":"109","author":"Chalasani","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jiac.2025.102789_bib44","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.22895","article-title":"Spanish Group for the Study of Drug-Induced Liver Disease. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex","volume":"49","author":"Lucena","year":"2009","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.jiac.2025.102789_bib45","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1001\/jama.2012.3507","article-title":"Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis","volume":"307","author":"Hempel","year":"2012","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jiac.2025.102789_bib46","first-page":"1276","article-title":"Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients","volume":"127","author":"Kadowaki","year":"2005","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.jiac.2025.102789_bib47","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J Clin Epidemiol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25001862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T02:11:43Z","timestamp":1762481503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25001862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1341321X25001862"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102789","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of and risk factors for side effects associated with antibiotic treatment for pneumonia","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102789"}}